Crypto Payments Push Gray-Market Peptide Sales to $100M Run Rate

On-chain sales of gray-market peptides reached an estimated $100 million annual run rate after crypto inflows rose 159% quarter‑over‑quarter to $32 million in the first quarter of 2026, blockchain analytics firm Chainalysis reported. The figure capped six consecutive quarters of growth for a market that averaged about $1 million per quarter through much of 2024.

Gray-market peptides are unbranded, unregulated versions of compounds used in some weight-loss and cosmetic treatments. Suppliers typically produce the products overseas and sell directly to buyers at prices well below pharmacy or clinic channels. Banks and card processors often refuse to process these transactions, and many participants have turned to cryptocurrency for payments.

Chainalysis traced the growth to a steady rise in crypto activity beginning in 2025 and accelerating in early 2026. The firm wrote, “This baseline shifted with the rise of the ‘MAHA’ (Make America Healthy Again) movement. In late 2025, the market collided with the ‘looksmaxxing’ ecosystem on TikTok and other social platforms.” The analytics firm linked those online communities to broader interest in peptide products and to increased use of crypto payment options.

The firm also documented changes in how vendors handle received funds. Smaller operators commonly held a mix of digital assets, while leading vendors increasingly rely on Bitcoin and stablecoins for receipts and settlements. Wholesale sellers that receive average deposits of $1,000 or more overwhelmingly use stablecoins. Stablecoins reduce exposure to sudden price swings and make it simpler to move funds across the supply chain.

Chainalysis described the pattern as a professionalizing shadow economy and noted that the coming quarters will determine whether the roughly $100 million annual pace holds amid rising attention from regulators and law enforcement. The firm’s data show how digital‑asset adoption is changing cross‑border sales of unregulated medical compounds, and how public blockchains can reveal volume and cash‑management practices even as participants seek to obscure links to regulated channels.